In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms
More than 50 years ago, the first concepts for gastroretentive drug delivery systems were developed. Despite extensive research in this field, there is no single formulation concept for which reliable gastroretention has been demonstrated under different prandial conditions. Thus, gastroretention re...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/8/416 |
id |
doaj-9a4e45ec8fe848da80d58dba400a0f82 |
---|---|
record_format |
Article |
spelling |
doaj-9a4e45ec8fe848da80d58dba400a0f822020-11-25T01:17:11ZengMDPI AGPharmaceutics1999-49232019-08-0111841610.3390/pharmaceutics11080416pharmaceutics11080416In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage FormsFelix Schneider0Mirko Koziolek1Werner Weitschies2Department of Biopharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, University of Greifswald, 17489 Greifswald, GermanyDepartment of Biopharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, University of Greifswald, 17489 Greifswald, GermanyDepartment of Biopharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, University of Greifswald, 17489 Greifswald, GermanyMore than 50 years ago, the first concepts for gastroretentive drug delivery systems were developed. Despite extensive research in this field, there is no single formulation concept for which reliable gastroretention has been demonstrated under different prandial conditions. Thus, gastroretention remains the holy grail of oral drug delivery. One of the major reasons for the various setbacks in this field is the lack of predictive in vitro and in vivo test methods used during preclinical development. In most cases, human gastrointestinal physiology is not properly considered, which leads to the application of inappropriate in vitro and animal models. Moreover, conditions in the stomach are often not fully understood. Important aspects such as the kinetics of fluid volumes, gastric pH or mechanical stresses have to be considered in a realistic manner, otherwise, the gastroretentive potential as well as drug release of novel formulations cannot be assessed correctly in preclinical studies. This review, therefore, highlights the most important aspects of human gastrointestinal physiology and discusses their potential implications for the evaluation of gastroretentive drug delivery systems.https://www.mdpi.com/1999-4923/11/8/416gastroretentiongastroretentive dosage formsin vitro testingdrug releasein vivo studies |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Felix Schneider Mirko Koziolek Werner Weitschies |
spellingShingle |
Felix Schneider Mirko Koziolek Werner Weitschies In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms Pharmaceutics gastroretention gastroretentive dosage forms in vitro testing drug release in vivo studies |
author_facet |
Felix Schneider Mirko Koziolek Werner Weitschies |
author_sort |
Felix Schneider |
title |
In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms |
title_short |
In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms |
title_full |
In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms |
title_fullStr |
In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms |
title_full_unstemmed |
In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms |
title_sort |
in vitro and in vivo test methods for the evaluation of gastroretentive dosage forms |
publisher |
MDPI AG |
series |
Pharmaceutics |
issn |
1999-4923 |
publishDate |
2019-08-01 |
description |
More than 50 years ago, the first concepts for gastroretentive drug delivery systems were developed. Despite extensive research in this field, there is no single formulation concept for which reliable gastroretention has been demonstrated under different prandial conditions. Thus, gastroretention remains the holy grail of oral drug delivery. One of the major reasons for the various setbacks in this field is the lack of predictive in vitro and in vivo test methods used during preclinical development. In most cases, human gastrointestinal physiology is not properly considered, which leads to the application of inappropriate in vitro and animal models. Moreover, conditions in the stomach are often not fully understood. Important aspects such as the kinetics of fluid volumes, gastric pH or mechanical stresses have to be considered in a realistic manner, otherwise, the gastroretentive potential as well as drug release of novel formulations cannot be assessed correctly in preclinical studies. This review, therefore, highlights the most important aspects of human gastrointestinal physiology and discusses their potential implications for the evaluation of gastroretentive drug delivery systems. |
topic |
gastroretention gastroretentive dosage forms in vitro testing drug release in vivo studies |
url |
https://www.mdpi.com/1999-4923/11/8/416 |
work_keys_str_mv |
AT felixschneider invitroandinvivotestmethodsfortheevaluationofgastroretentivedosageforms AT mirkokoziolek invitroandinvivotestmethodsfortheevaluationofgastroretentivedosageforms AT wernerweitschies invitroandinvivotestmethodsfortheevaluationofgastroretentivedosageforms |
_version_ |
1725147542208905216 |